Helix BioMedix, Inc. 

(Public, OTC:HXBM)   Watch this stock   
Find more results for HXBM
Nov 6, 2009
Q3 2009 HELIX BIOMEDIX INC Earnings Release
  

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -742.03% -803.56%
Operating margin -634.06% -630.78%
EBITD margin - -606.94%
Return on average assets -103.09% -191.11%
Return on average equity - -
Employees 6 -

Address

22118-20th Avenue Southeast Suite 204
Bothell, WA 98021
United States - Map
+1-425-4028400 (Phone)

Website links

Helix BioMedix, Inc. discussed on blogs

Ranking All OTC Stocks by Weekly Performance - NASD100.com - Daily ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 21, 2009

Helix BioMedix, Inc. discussions

  View all discussions »

Description

Helix BioMedix, Inc., is a biopharmaceutical company with a library of structurally bioactive peptides and patents covering hundreds of thousands of peptide sequences. The Company has developed short, small-chain peptides with anti-infective, anti-inflammatory properties and modulatory properties, such as the stimulation of cell proliferation and migration. These peptides are targeted for use as ingredients in cosmetics and topical therapeutics. The applications include anti-aging skin care, acne treatment, wound healing and the treatment and prevention of infections. The Company has also developed numerous peptide sequences in the two areas of application, which includes consumer (skin care) and pharmaceutical. The Company has developed a number of peptides capable of stimulating certain aspects of the skin’s innate ability to regenerate and is marketing these peptides as ingredients for cosmetic use.

Officers and directors

R. Stephen Beatty
President, Chief Executive Officer, Chief Financial Officer, Director
Age: 59
Timothy J. Falla Ph.D.
Vice President, Chief Scientific Officer
Age: 43
Robin L. Carmichael
Vice President - Marketing and Business Development
Age: 52
Jeffrey A. Miller Ph.D.
Director
Age: 61
Randall L-W. Caudill Ph.D., D. Phil.
Director
Age: 62
Daniel O. Wilds
Director
Age: 60
John C. Fiddes Ph.D.
Director
Age: 57
Barry L. Seidman
Director
Age: 63